Page last updated: 2024-09-02

dihydrokainate and zm 241385

dihydrokainate has been researched along with zm 241385 in 1 studies

Compound Research Comparison

Studies
(dihydrokainate)
Trials
(dihydrokainate)
Recent Studies (post-2010)
(dihydrokainate)
Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010) (zm 241385)
1800464013124

Protein Interaction Comparison

ProteinTaxonomydihydrokainate (IC50)zm 241385 (IC50)
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0949
Adenosine receptor A2aHomo sapiens (human)0.0216
Adenosine receptor A2bHomo sapiens (human)0.0646

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galluzzo, M; Grieco, R; Pèzzola, A; Pintor, A; Popoli, P; Reggio, R1

Other Studies

1 other study(ies) available for dihydrokainate and zm 241385

ArticleYear
Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
    Journal of neurochemistry, 2004, Volume: 89, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Dicarboxylic Acids; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Glutamic Acid; Kainic Acid; Male; Microdialysis; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Pyrimidines; Pyrrolidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles

2004